10 20 30 40 50 60 70 80 1YOW - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER TRANSCRIPTION 28-JAN-05 1YOW
TITLE HUMAN STEROIDOGENIC FACTOR 1 LBD WITH BOUND CO-FACTOR TITLE 2 PEPTIDE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: STEROIDOGENIC FACTOR 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: STF-1, SF-1, ADRENAL 4 BINDING PROTEIN, STEROID COMPND 5 HORMONE RECEPTOR AD4BP, FUSHI TARAZU FACTOR HOMOLOG 1; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: TIF2 PEPTIDE; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR5A1, AD4BP, FTZF1, SF1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 [DE3]; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SOURCE 12 SEQUENCE OF THE PEPTIDE IS NATURALLY FOUND IN HOMO SAPIENS SOURCE 13 (HUMAN).
KEYWDS STEROIDOGENIC FACTOR 1, SF1, PHOSPHOLIPID, PHOSPHATIDYL KEYWDS 2 ETHANOLAMINE, PHOSPHATIDYL GLYCEROL, TRANSCRIPTION
EXPDTA X-RAY DIFFRACTION
AUTHOR I.N.KRYLOVA,E.P.SABLIN,R.X.XU,G.M.WAITT,D.JUZUMIENE, AUTHOR 2 J.D.WILLIAMS,H.A.INGRAHAM,T.M.WILLSON,S.P.WILLIAMS, AUTHOR 3 V.MONTANA,K.P.MADAUSS,J.MOORE,J.M.BYNUM,L.LEBEDEVA, AUTHOR 4 J.A.MACKAY,M.SUZAWA,R.K.GUY,J.W.THORNTON
REVDAT 2 24-FEB-09 1YOW 1 VERSN REVDAT 1 10-MAY-05 1YOW 0
JRNL AUTH I.N.KRYLOVA,E.P.SABLIN,R.X.XU,G.M.WAITT,J.A.MACKAY, JRNL AUTH 2 D.JUZUMIENE,J.M.BYNUM,K.P.MADAUSS,V.MONTANA, JRNL AUTH 3 L.LEBEDEVA,M.SUZAWA,J.D.WILLIAMS,S.P.WILLIAMS, JRNL AUTH 4 R.K.GUY,J.W.THORNTON,R.J.FLETTERICK,T.M.WILLSON, JRNL AUTH 5 H.A.INGRAHAM JRNL TITL STRUCTURAL ANALYSES REVEAL PHOSPHATIDYL INOSITOLS JRNL TITL 2 AS LIGANDS FOR THE NR5 ORPHAN RECEPTORS SF-1 AND JRNL TITL 3 LRH-1 JRNL REF CELL(CAMBRIDGE,MASS.) V. 120 343 2005 JRNL REFN ISSN 0092-8674 JRNL PMID 15707893 JRNL DOI 10.1016/J.CELL.2005.01.024
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : CNX LIBRARY REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.8 REMARK 3 NUMBER OF REFLECTIONS : 8080 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.246 REMARK 3 FREE R VALUE : 0.290 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 596 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1856 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 96 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 86.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : -0.24 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.24000 REMARK 3 B22 (A**2) : -0.24000 REMARK 3 B33 (A**2) : -0.24000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : 20.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : 1.34 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: SIMULATED ANNEALING FOLLOWED BY CG REMARK 3 MINIMIZATION
REMARK 4 REMARK 4 1YOW COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-MAY-05. REMARK 100 THE RCSB ID CODE IS RCSB031764.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-DEC-02; NULL REMARK 200 TEMPERATURE (KELVIN) : 100; NULL REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; Y REMARK 200 RADIATION SOURCE : APS; APS REMARK 200 BEAMLINE : 17-ID; 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0; 1.0, 0.979, 0.985 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL; SI 111 CHANNEL REMARK 200 OPTICS : MIRRORS; NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD; NULL REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210; NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8888 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 10.000 REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 36.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 10.00 REMARK 200 R MERGE FOR SHELL (I) : 0.43600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M NACITRATE PH5.6, 0.2M LI2SO4, REMARK 280 25% PEG3350, VAPOR DIFFUSION, HANGING DROP
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 69.51050 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 36.66750 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 36.66750 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 34.75525 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 36.66750 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 36.66750 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 104.26575 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 36.66750 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 36.66750 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 34.75525 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 36.66750 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 36.66750 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 104.26575 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 69.51050 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2180 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11920 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 220 REMARK 465 PRO A 251 REMARK 465 THR A 252 REMARK 465 LYS A 253 REMARK 465 SER A 254 REMARK 465 ARG A 255 REMARK 465 PRO A 256 REMARK 465 ASP A 257 REMARK 465 GLN A 258 REMARK 465 LYS A 459 REMARK 465 GLN A 460 REMARK 465 THR A 461
REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 221 OG REMARK 470 GLN A 232 CG CD OE1 NE2 REMARK 470 VAL A 240 CG1 CG2 REMARK 470 ARG A 243 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 244 CG1 CG2 CD1 REMARK 470 GLU A 250 CG CD OE1 OE2 REMARK 470 PRO A 259 CG CD REMARK 470 ARG A 267 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 281 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 282 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 290 CG CD OE1 OE2 REMARK 470 ARG A 365 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 396 CG CD CE NZ REMARK 470 LEU A 406 CG CD1 CD2 REMARK 470 CYS A 412 SG REMARK 470 LYS A 434 CG CD CE NZ REMARK 470 ASN A 449 CG OD1 ND2
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 284 -102.54 -64.92 REMARK 500 LYS A 319 161.34 -47.53 REMARK 500 THR A 327 -77.88 -63.22 REMARK 500 GLN A 329 171.20 -54.23 REMARK 500 HIS A 387 -85.67 -46.24 REMARK 500 TYR A 409 71.16 -114.99 REMARK 500 GLN B 599 -67.40 -91.79 REMARK 500 LEU B 605 -78.46 -59.98 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 2 DISTANCE = 8.98 ANGSTROMS REMARK 525 HOH B 75 DISTANCE = 5.42 ANGSTROMS REMARK 525 HOH A 4 DISTANCE = 7.45 ANGSTROMS REMARK 525 HOH A 6 DISTANCE = 7.34 ANGSTROMS REMARK 525 HOH A 14 DISTANCE = 7.70 ANGSTROMS REMARK 525 HOH A 15 DISTANCE = 5.36 ANGSTROMS REMARK 525 HOH A 17 DISTANCE = 5.56 ANGSTROMS REMARK 525 HOH A 19 DISTANCE = 6.52 ANGSTROMS REMARK 525 HOH A 24 DISTANCE = 5.88 ANGSTROMS REMARK 525 HOH A 27 DISTANCE = 7.89 ANGSTROMS REMARK 525 HOH A 28 DISTANCE = 5.55 ANGSTROMS REMARK 525 HOH A 33 DISTANCE = 7.38 ANGSTROMS REMARK 525 HOH A 35 DISTANCE = 9.21 ANGSTROMS REMARK 525 HOH A 36 DISTANCE = 10.79 ANGSTROMS REMARK 525 HOH A 38 DISTANCE = 5.73 ANGSTROMS REMARK 525 HOH A 41 DISTANCE = 7.22 ANGSTROMS REMARK 525 HOH A 43 DISTANCE = 11.23 ANGSTROMS REMARK 525 HOH A 48 DISTANCE = 5.02 ANGSTROMS REMARK 525 HOH A 51 DISTANCE = 7.53 ANGSTROMS REMARK 525 HOH A 52 DISTANCE = 9.57 ANGSTROMS REMARK 525 HOH A 54 DISTANCE = 10.43 ANGSTROMS REMARK 525 HOH A 56 DISTANCE = 5.35 ANGSTROMS REMARK 525 HOH A 62 DISTANCE = 14.43 ANGSTROMS REMARK 525 HOH A 67 DISTANCE = 6.26 ANGSTROMS REMARK 525 HOH A 68 DISTANCE = 8.66 ANGSTROMS REMARK 525 HOH A 73 DISTANCE = 6.52 ANGSTROMS REMARK 525 HOH A 77 DISTANCE = 7.30 ANGSTROMS REMARK 525 HOH A 87 DISTANCE = 9.00 ANGSTROMS REMARK 525 HOH A 89 DISTANCE = 6.78 ANGSTROMS REMARK 525 HOH A 94 DISTANCE = 10.13 ANGSTROMS REMARK 525 HOH A 95 DISTANCE = 10.72 ANGSTROMS
REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 P0E A 201
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P0E A 201
DBREF 1YOW A 222 461 UNP Q13285 STF1_HUMAN 222 461 DBREF 1YOW B 598 608 PDB 1YOW 1YOW 598 608
SEQADV 1YOW GLY A 220 UNP Q13285 CLONING ARTIFACT SEQADV 1YOW SER A 221 UNP Q13285 CLONING ARTIFACT SEQADV 1YOW MET A 227 UNP Q13285 ILE 227 CLONING ARTIFACT
SEQRES 1 A 242 GLY SER ASN VAL PRO GLU LEU MET LEU GLN LEU LEU GLN SEQRES 2 A 242 LEU GLU PRO ASP GLU ASP GLN VAL ARG ALA ARG ILE LEU SEQRES 3 A 242 GLY CYS LEU GLN GLU PRO THR LYS SER ARG PRO ASP GLN SEQRES 4 A 242 PRO ALA ALA PHE GLY LEU LEU CYS ARG MET ALA ASP GLN SEQRES 5 A 242 THR PHE ILE SER ILE VAL ASP TRP ALA ARG ARG CYS MET SEQRES 6 A 242 VAL PHE LYS GLU LEU GLU VAL ALA ASP GLN MET THR LEU SEQRES 7 A 242 LEU GLN ASN CYS TRP SER GLU LEU LEU VAL PHE ASP HIS SEQRES 8 A 242 ILE TYR ARG GLN VAL GLN HIS GLY LYS GLU GLY SER ILE SEQRES 9 A 242 LEU LEU VAL THR GLY GLN GLU VAL GLU LEU THR THR VAL SEQRES 10 A 242 ALA THR GLN ALA GLY SER LEU LEU HIS SER LEU VAL LEU SEQRES 11 A 242 ARG ALA GLN GLU LEU VAL LEU GLN LEU LEU ALA LEU GLN SEQRES 12 A 242 LEU ASP ARG GLN GLU PHE VAL CYS LEU LYS PHE ILE ILE SEQRES 13 A 242 LEU PHE SER LEU ASP LEU LYS PHE LEU ASN ASN HIS ILE SEQRES 14 A 242 LEU VAL LYS ASP ALA GLN GLU LYS ALA ASN ALA ALA LEU SEQRES 15 A 242 LEU ASP TYR THR LEU CYS HIS TYR PRO HIS CYS GLY ASP SEQRES 16 A 242 LYS PHE GLN GLN LEU LEU LEU CYS LEU VAL GLU VAL ARG SEQRES 17 A 242 ALA LEU SER MET GLN ALA LYS GLU TYR LEU TYR HIS LYS SEQRES 18 A 242 HIS LEU GLY ASN GLU MET PRO ARG ASN ASN LEU LEU ILE SEQRES 19 A 242 GLU MET LEU GLN ALA LYS GLN THR SEQRES 1 B 11 ALA GLN ALA LEU ALA ALA LEU LEU ALA LYS ALA
HET P0E A 201 46
HETNAM P0E PHOSPHATIDYL ETHANOL
HETSYN P0E (2S)-2-[(9E)-HEXADEC-9-ENOYLOXY]-3-{[HYDROXY(2- HETSYN 2 P0E HYDROXYETHOXY)PHOSPHORYL]OXY}PROPYL (9E)-OCTADEC-9- HETSYN 3 P0E ENOATE
FORMUL 3 P0E C39 H73 O9 P FORMUL 4 HOH *96(H2 O)
HELIX 1 1 PRO A 224 LEU A 233 1 10 HELIX 2 2 ASP A 236 GLN A 249 1 14 HELIX 3 3 PRO A 259 ARG A 282 1 24 HELIX 4 4 CYS A 283 GLU A 288 1 6 HELIX 5 5 GLU A 290 GLY A 318 1 29 HELIX 6 6 LEU A 333 ALA A 340 1 8 HELIX 7 7 GLY A 341 LEU A 361 1 21 HELIX 8 8 ASP A 364 PHE A 377 1 14 HELIX 9 9 ASP A 380 LEU A 384 5 5 HELIX 10 10 ASN A 386 TYR A 409 1 24 HELIX 11 11 ASP A 414 GLY A 443 1 30 HELIX 12 12 ASN A 450 GLN A 457 1 8 HELIX 13 13 LEU B 601 ALA B 606 1 6
SHEET 1 A 2 SER A 322 LEU A 324 0 SHEET 2 A 2 GLU A 330 GLU A 332 -1 O VAL A 331 N ILE A 323
SITE 1 AC1 19 PHE A 262 LEU A 265 SER A 303 LEU A 306 SITE 2 AC1 19 VAL A 307 HIS A 310 ILE A 323 VAL A 331 SITE 3 AC1 19 THR A 335 VAL A 336 GLN A 339 ALA A 340 SITE 4 AC1 19 GLY A 341 LEU A 344 ALA A 351 SER A 430 SITE 5 AC1 19 ALA A 433 TYR A 436 LYS A 440
CRYST1 73.335 73.335 139.021 90.00 90.00 90.00 P 41 21 2 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.013636 0.000000 0.000000 0.00000
SCALE2 0.000000 0.013636 0.000000 0.00000
SCALE3 0.000000 0.000000 0.007193 0.00000